Head-to-head
TMates vs Gala GLP-1
Compared on both medications across the eight dimensions this database records. They differ on 4 of those eight. Gala GLP-1 is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
TMates is $297 a month all-in for tirzepatide; Gala GLP-1 is $179. Over twelve months that is $2,004 against $2,148. Value Scores are 55.3 and 91.6 out of 100.
Tirzepatide
Plan pages: TMates plans · Gala GLP-1 plans
At 10 mg/week, TMates is $297 a month all-in and Gala GLP-1 is $179 — $118 apart, or $1,416 across a year. Over twelve months the totals are $2,004 (prepaid term) and $2,148 (billed monthly).
TMates charges a flat $297 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.
Gala GLP-1 charges a flat $179 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
| Dose | TMates | Rank | Gala GLP-1 | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $297 | 16/31 | $179 | 4/31 | Gala GLP-1 by $118 |
| 5 mg | — | — | $179 | 2/17 | only Gala GLP-1 publishes |
| 7.5 mg | — | — | $179 | 2/17 | only Gala GLP-1 publishes |
| 10 mg | $297 | 12/27 | $179 | 2/27 | Gala GLP-1 by $118 |
| 12.5 mg | — | — | $179 | 2/17 | only Gala GLP-1 publishes |
| 15 mg | — | — | $179 | 2/17 | only Gala GLP-1 publishes |
Gala GLP-1 is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 27 programs this database can rank on tirzepatide, TMates sits 10 of 27 on all-in monthly cost and Gala GLP-1 sits 3. There are 6 other programs priced between them. The field median is $339 and the floor is $169, so both sit below the median. TMates is $128 above the cheapest tirzepatide program on record. Gala GLP-1 is $10 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — TMates undercuts it by $152, Gala GLP-1 by $270. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | TMates | Gala GLP-1 | Cheaper |
|---|---|---|---|
| Month to month | $297 | $179 | Gala GLP-1 by $118 |
| 3-month term | — | $199 | only Gala GLP-1 publishes this term |
| 12-month term | $167 | — | only TMates publishes this term |
| Settled dose | TMates | Gala GLP-1 | Difference |
|---|---|---|---|
| 2.5 mg | $3,564 | $2,148 | $1,416 apart |
| 5 mg | — | $2,148 | one side unpriced |
| 7.5 mg | — | $2,148 | one side unpriced |
| 10 mg | $3,564 | $2,148 | $1,416 apart |
| 12.5 mg | — | $2,148 | one side unpriced |
| 15 mg | — | $2,148 | one side unpriced |
TMates publishes no rate for 3-month term, 6-month term; Gala GLP-1 publishes none for 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $3,564 on TMates and $2,148 on Gala GLP-1. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
That calculation is partial: TMates publishes no price at 2 of the 6 doses, so the maintenance rate stands in for the missing steps rather than a number the company has stated.
Value Scores are 55.3 for TMates and 91.6 for Gala GLP-1, against a tirzepatide category floor of $169. Gala GLP-1 leads by 36.3 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| TMates | 39.8 | 10.5 | 0 | 5 | 55.3 |
| Gala GLP-1 | 66.1 | 10.5 | 10 | 5 | 91.6 |
Semaglutide
Plan pages: TMates plans · Gala GLP-1 plans
At 2.4 mg/week, TMates is $249 a month all-in and Gala GLP-1 is $179 — $70 apart, or $840 across a year. Over twelve months the totals are $1,896 (prepaid term) and $2,148 (billed monthly).
TMates charges a flat $249 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.
Gala GLP-1 charges a flat $179 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Gala GLP-1 is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Value Scores are 51.8 for TMates and 75.9 for Gala GLP-1, against a semaglutide category floor of $129. Gala GLP-1 leads by 24.1 points, driven mostly by price.
Where the two programs differ
All-in monthly
Gala GLP-1 is cheaper month to month — $179 against $297, a gap of $118 every month, or $1,416 across a year if both rates hold.
Commitment
TMates asks for 12-month plan or month-to-month; substantial difference in rates; Gala GLP-1 asks for 3-month plan or standard monthly; confirm exact terms at enrollment. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
Gala GLP-1 charges one price at every dose; TMates prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Twelve-month cost
Over twelve months the totals are $2,004 for TMates and $2,148 for Gala GLP-1. TMates is lower by $144 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Cancellation terms
Both state the same cancellation terms: Per provider terms.
Evidence status
Both figures carry the same evidence status, reported: sourced from dated third-party reporting; first-party capture pending. Neither is stronger than the other on provenance.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
TMates Official site
TMates is a compounded GLP-1 telehealth service that includes medication and visits in one bundled monthly price. It offers both semaglutide and tirzepatide, with a 12-month plan that brings tirzepatide to $167/mo — the lowest committed-plan figure for tirz outside of bmiMD and NexLife.
It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacy (not publicly named), so who actually makes the medication cannot be independently verified; commitment terms are 12-month plan or month-to-month; substantial difference in rates; cancellation is Per provider terms; availability is stated as Confirm at intake.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, capture 2026-07-14
Watch: The $158/mo (sema) and $167/mo (tirz) headline figures are 12-month plan rates; month-to-month is $249 (sema) and $297 (tirz) — some of the widest start-to-commitment spreads in the index. Reported status from RangeYourself 2026-07-14 verification.
Gala GLP-1 Official site
Gala GLP-1 is an all-50-state compounded GLP-1 service offering a range of pricing by product tier, including a microdosing option. Its standard all-dose rate is $179/mo (tirz) and $179/mo (sema) with a microdosing tier starting at $149.
It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacies (not named publicly), so who actually makes the medication cannot be independently verified; commitment terms are 3-month plan or standard monthly; confirm exact terms at enrollment; cancellation is Per provider terms; availability is stated as All 50 states (per provider claim; confirm at intake).
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, capture 2026-07-14
Watch: Gala lists a range rather than one fixed price: the hero says $179/mo 'all doses', the FAQ says $199/mo 'with a 3-month plan', and $149/mo is listed for microdosing. This makes 'all-in maintenance' ambiguous; we rank on the $179 standard figure with a note. Exact ongoing rate must be confirmed at enrollment. Reported status from RangeYourself 2026-07-14.
What neither record tells you
TMates does not publish
- no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
- no semaglutide price at 0.5, 1, 1.7 mg per week
- no named compounding pharmacy
- no state-by-state availability list — it says Confirm at intake
- no specific cancellation or refund terms
Gala GLP-1 does not publish
- no published twelve-month tirzepatide rate
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says All 50 states (per provider claim; confirm at intake)
- no specific cancellation or refund terms
Ask TMates and Gala GLP-1 for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. TMates, Gala GLP-1 carry a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Prepaid terms move the annual figures. TMates publishes a twelve-month rate of $167 a month against $297 month-to-month. Read those next to the cancellation terms, not the monthly rate.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, Gala GLP-1 Official site wins this matchup. If you expect to titrate to the top of the ladder, gala glp-1's flat pricing is worth more than the headline gap suggests.
Both figures should be checked at the provider's own checkout before you pay. TMates's tirzepatide price is reported as of 2026-07-14; Gala GLP-1's is reported as of 2026-07-14.
Questions
Is TMates or Gala GLP-1 cheaper for tirzepatide?
Gala GLP-1 is cheaper on all-in monthly cost at 10 mg/week: $179 against $297, a difference of $118 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of TMates versus Gala GLP-1?
TMates works out to $2,004 across twelve months and Gala GLP-1 to $2,148, on the plan terms each publishes.
Does TMates or Gala GLP-1 raise the price as the dose goes up?
TMates: yes, it prices by dose. Gala GLP-1: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do TMates and Gala GLP-1 differ?
4 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of TMates and Gala GLP-1 names its pharmacy?
Neither. TMates records Partner 503A pharmacy (not publicly named) and Gala GLP-1 records Partner 503A pharmacies (not named publicly). Without a named pharmacy, neither program's licensing or inspection history can be checked before you order.
How well evidenced are the TMates and Gala GLP-1 prices?
TMates's tirzepatide figure is reported — sourced from dated third-party reporting; first-party capture pending — captured 2026-07-14. Gala GLP-1's is reported, captured 2026-07-14. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Which is cheaper for semaglutide?
Gala GLP-1, at $179 a month all-in against $249 at 2.4 mg/week. The two programs do not necessarily lead on both medications.
Official sources: TMates official site · Gala GLP-1 official site. Compounded tirzepatide and semaglutide are not FDA-approved products.